Table 3.
Pregnancy and delivery characteristics and obstetrical outcomes.
| Pregnancy and delivery characteristics | Group 1 (n = 353) | Group 2 (n = 146) | p |
|---|---|---|---|
| Term (WG) | |||
| Total population (n = 499) | 39.09 ± 1.92 | 39.42 ± 1.4 | 0.14 |
| Non-analysed patients (n = 226) | 39.14 ± 2.08 | 39.48 ± 1.33 | 0.35 |
| Analysed patients (n = 273) | 39.05 ± 1.78 | 39.37 ± 1.47 | 0.26 |
| Insulin therapy | |||
| Total population (n = 499) | 169 (49.1%) | 49 (34.8%) | 0.005 |
| Non-analysed patients (n = 226) | 63 (41.4%) | 24 (37.5%) | 0.65 |
| Analysed patients (n = 273) | 106 (52.2%)* | 25 (32.5%) | < 0.001 |
| Preeclampsia | |||
| Total population (n = 499) | 9 (2.6%) | 1 (0.7%) | 0.29 |
| Non-analysed patients (n = 226) | 4 (2.7%) | 0 | 0.32 |
| Analysed patients (n = 273) | 5 (2.6%) | 1 (1.3%) | 0.68 |
| Thrombocytopenia | |||
| Total population (n = 499) | 10 (2.9%) | 4 (2.8%) | 1 |
| Non-analysed patients (n = 226) | 4 (2.7%) | 0 | 0.32 |
| Analysed patients (n = 273) | 6 (3.2%) | 4 (5.2%) | 0.48 |
| Gestational hypertension | |||
| Total population (n = 499) | 11 (3.2%) | 2 (1.4%) | 0.36 |
| Non-analysed patients (n = 226) | 5 (3.4%) | 1 (1.6%) | 0.67 |
| Analysed patients (n = 273) | 6 (3.2%) | 1 (1.3%) | 0.68 |
| Preterm labour | |||
| Total population (n = 499) | 10 (2.9%) | 10 (7.1%) | 0.045 |
| Non-analysed patients (n = 226) | 5 (3.3%) | 3 (4.7%) | 0.70 |
| Analysed patients (n = 273) | 5 (2.6%) | 7 (9.1%) | 0.043 |
| Urinary tract infection | |||
| Total population (n = 499) | 11 (3.2%) | 6 (4.3%) | 0.59 |
| Non-analysed patients (n = 226) | 5 (3.3%) | 4 (6.3%) | 0.46 |
| Analysed patients (n = 273) | 6 (3.2%) | 2 (2.6%) | 1 |
| Weight gain during pregnancy (kg) | |||
| Total population (n = 499) | 7.56 ± 6.33 | 9.82 ± 5.52 | < 0.001 |
| Non-analysed patients (n = 226) | 8.48 ± 6.38 | 10.78 ± 5.09 | 0.003 |
| Analysed patients (n = 273) | 6.82 ± 6.22* | 9.03 ± 5.77* | 0.006 |
| Labour induction | |||
| Total population (n = 499) | 127 (36.8%) | 43 (29.9%) | 0.15 |
| Non-analysed patients (n = 226) | 54 (35.3%) | 23 (35.9%) | 1 |
| Analysed patients (n = 273) | 73 (38.0%) | 20 (25%) | 0.049 |
| Failed labour induction | |||
| Total population (n = 499) | 23 (18.5%) | 5 (11.9%) | 0.47 |
| Non-analysed patients (n = 226) | 16 (29.6%) | 3 (13.6%) | 0.24 |
| Analysed patients (n = 273) | 7 (10%)* | 2 (10%) | 1 |
| Dystocia | |||
| Total population (n = 499) | 31 (9.5%) | 16 (11.6%) | 0.50 |
| Non-analysed patients (n = 226) | 15 (10.6%) | 7 (11.1%) | 1 |
| Analysed patients (n = 273) | 16 (8.6%) | 9 (12%) | 0.49 |
| Caesarean | |||
| Total population (n = 499) | 109 (31.6%) | 23 (16%) | < 0.001 |
| Non-analysed patients (n = 226) | 56 (36.6%) | 9 (14.1%) | 0.001 |
| Analysed patients (n = 273) | 53 (27.6%) | 14 (17.5%) | 0.09 |
| Planned caesarean | |||
| Total population (n = 499) | 46 (42.2%) | 10 (43.5%) | 1 |
| Non-analysed patients (n = 226) | 22 (39.3%) | 6 (66.7%) | 0.16 |
| Analysed patients (n = 273) | 24 (45.3%) | 4 (28.6%) | 0.36 |
| Obstetrical outcomes | |||
| Maternal complications | |||
| Total population (n = 499) | 63 (18.3%) | 21 (14.6%) | 0.36 |
| Non-analysed patients (n = 226) | 29 (19.1%) | 7 (10.9%) | 0.17 |
| Analysed patients (n = 273) | 34 (17.7%) | 14 (17.5%) | 1 |
| Macrosomia (birth weight ≥ 4000 g) | |||
| Total population (n = 499) | 32 (9.4%) | 12 (8.3%) | 0.85 |
| Non-analysed patients (n = 226) | 18 (11.8%) | 6 (9.5%) | 0.80 |
| Analysed patients (n = 273) | 14 (7.4%) | 6 (7.4%) | 1 |
| Foetal complications | |||
| Total population (n = 499) | 106 (30.7%) | 53 (36.6%) | 0.24 |
| Non-analysed patients (n = 226) | 50 (32.7%) | 19 (29.7%) | 0.75 |
| Analysed patients (n = 273) | 56 (29.2%) | 34 (42.0%) | 0.048 |
| Birth weight (g) | |||
| Total population (n = 499) | 3344.07 ± 555.88 | 3337.87 ± 454.01 | 0.41 |
| Non-analysed patients (n = 226) | 3415.41 ± 582.2 | 3338.02 ± 446.56 | 0.10 |
| Analysed patients (n = 273) | 3287 ± 528.52 | 3337.75 ± 462.55 | 0.72 |
Statistically significant p values between groups are given in bold.
Data are presented as number (%) or average ± standard deviation. *p < 0.05 for the comparison between Non-analysed and Analysed patients.